Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Rigo

Showing results (11-20 of 163) with videos related to

Pageof 17
Sort By:
Frontiers in Neuroscience|October 30, 2023
Reduction of <i>Kcnt1</i> is therapeutic in mouse models of <i>SCN1A</i> and <i>SCN8A</i> epilepsySophie F Hill, Paymaan Jafar-Nejad, Frank Rigo, et al.
Molecular Therapy. Nucleic Acids|April 10, 2019
Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein ReceptorJuergen Scharner, Sabrina Qi, Frank Rigo, et al.
Nucleic Acids Research|February 28, 2020
Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse modelLei Sheng, Frank Rigo, C Frank Bennett, et al.
Nucleic Acids Research|March 5, 2014
Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotidesAmanda J Ward, Michaela Norrbom, Seung Chun, et al.
Open Biology|November 17, 2012
Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotidesZhenxun Wang, Hyun Yong Jeon, Frank Rigo, et al.
Experimental Cell Research|August 4, 2024
Targeting alternative splicing of fibronectin in human renal proximal tubule epithelial cells with antisense oligonucleotides to reduce EDA+ fibronectin production and block an autocrine loop that drives renal fibrosisMysore Keshavmurthy Phanish, Felicia Heidebrecht, Michaela Jackson, et al.
Epilepsia|July 27, 2022
Genetic interaction between Scn8a and potassium channel genes Kcna1 and Kcnq2Sophie F Hill, Julie M Ziobro, Paymaan Jafar-Nejad, et al.
Cell Reports|December 15, 2021
Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degenerationStacey Anne Gould, Jonathan Gilley, Karen Ling, et al.
Nature|December 4, 2014
Towards a therapy for Angelman syndrome by targeting a long non-coding RNALinyan Meng, Amanda J Ward, Seung Chun, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 MiceLodewijk J A Toonen, Frank Rigo, Haico van Attikum, et al.
Pageof 17

Showing results (11-20 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Neuroscience|October 30, 2023
Reduction of <i>Kcnt1</i> is therapeutic in mouse models of <i>SCN1A</i> and <i>SCN8A</i> epilepsySophie F Hill, Paymaan Jafar-Nejad, Frank Rigo, et al.
Molecular Therapy. Nucleic Acids|April 10, 2019
Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein ReceptorJuergen Scharner, Sabrina Qi, Frank Rigo, et al.
Nucleic Acids Research|February 28, 2020
Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse modelLei Sheng, Frank Rigo, C Frank Bennett, et al.
Nucleic Acids Research|March 5, 2014
Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotidesAmanda J Ward, Michaela Norrbom, Seung Chun, et al.
Open Biology|November 17, 2012
Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotidesZhenxun Wang, Hyun Yong Jeon, Frank Rigo, et al.
Experimental Cell Research|August 4, 2024
Targeting alternative splicing of fibronectin in human renal proximal tubule epithelial cells with antisense oligonucleotides to reduce EDA+ fibronectin production and block an autocrine loop that drives renal fibrosisMysore Keshavmurthy Phanish, Felicia Heidebrecht, Michaela Jackson, et al.
Epilepsia|July 27, 2022
Genetic interaction between Scn8a and potassium channel genes Kcna1 and Kcnq2Sophie F Hill, Julie M Ziobro, Paymaan Jafar-Nejad, et al.
Cell Reports|December 15, 2021
Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degenerationStacey Anne Gould, Jonathan Gilley, Karen Ling, et al.
Nature|December 4, 2014
Towards a therapy for Angelman syndrome by targeting a long non-coding RNALinyan Meng, Amanda J Ward, Seung Chun, et al.
Molecular Therapy. Nucleic Acids|September 18, 2017
Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 MiceLodewijk J A Toonen, Frank Rigo, Haico van Attikum, et al.
Pageof 17